Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Friday's Pre-Market Session

Author: Benzinga Insights | April 29, 2022 07:16am

 

Gainers

  • Finch Therapeutics Group (NASDAQ:FNCH) stock increased by 55.7% to $3.27 during Friday's pre-market session. The company's market cap stands at $155.5 million.
  • Zymeworks (NYSE:ZYME) stock rose 47.78% to $7.33. The company's market cap stands at $423.2 million.
  • Summit Therapeutics (NASDAQ:SMMT) stock moved upwards by 40.36% to $2.33. The company's market cap stands at $228.6 million.
  • NuCana (NASDAQ:NCNA) stock moved upwards by 9.45% to $0.81. The company's market cap stands at $42.2 million. As per the press release, Q4 earnings came out 2 days ago.
  • 4d pharma (NASDAQ:LBPS) stock increased by 9.06% to $3.85. The company's market cap stands at $86.7 million.
  • Aquestive Therapeutics (NASDAQ:AQST) shares rose 8.63% to $1.51. The market value of their outstanding shares is at $62.5 million.

Losers

  • Genocea Biosciences (NASDAQ:GNCA) shares declined by 43.4% to $0.23 during Friday's pre-market session. The market value of their outstanding shares is at $13.5 million.
  • Accolade (NASDAQ:ACCD) shares fell 41.51% to $6.47. The market value of their outstanding shares is at $433.2 million. As per the news, the Q4 earnings report came out yesterday.
  • Statera BioPharma (NASDAQ:STAB) stock fell 15.82% to $0.32. The market value of their outstanding shares is at $16.0 million.
  • Aldeyra Therapeutics (NASDAQ:ALDX) stock fell 12.06% to $3.21. The company's market cap stands at $187.1 million.
  • Evoke Pharma (NASDAQ:EVOK) shares declined by 11.63% to $0.44. The company's market cap stands at $14.4 million.
  • Aclarion (NASDAQ:ACON) stock declined by 7.84% to $2.0. The market value of their outstanding shares is at $15.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACCD ACON ALDX AQST EVOK FNCH GNCA LBPS NCNA SMMT STAB ZYME

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist